Skip to main content
Top
Published in: BMC Cancer 1/2015

Open Access 01-12-2015 | Case report

The diagnostic challenge of pulmonary tumour thrombotic microangiopathy as a presentation for metastatic gastric cancer: a case report and review of the literature

Authors: Andrew LK. Ho, Patryk Szulakowsi, Waria HS. Mohamid

Published in: BMC Cancer | Issue 1/2015

Login to get access

Abstract

Background

Pulmonary tumour thrombotic microangiopathy (PTTM) is a rare complication of metastatic cancer with a distinct histological appearance which presents with dyspnoea and pulmonary arterial hypertension and leads to death in hours to days. It is a challenging diagnosis to make ante mortem, in part due to the rapid clinical decline. Herein, we report a case of a young woman initially felt to have pulmonary sarcoidosis but who then died eight days later from what was found at post mortem to be PTTM.

Case presentation

A 41 year old Caucasian woman presented with progressive dyspnoea. Computed tomography of her thorax showed diffuse tiny centrilobular nodules in a tree-in-bud appearance along with small volume mediastinal lymphadenopathy. A presumptive diagnosis of pulmonary sarcoidosis was made; bronchoscopy with transbronchial lung biopsy was arranged to confirm the diagnosis. However, she rapidly deteriorated and died eight days later. Post mortem examination revealed metastatic poorly differentiated gastric adenocarcinoma with PTTM being the final cause of death.

Conclusion

This case demonstrates the diagnostic difficulties in such a rare and rapidly fatal oncological complication; a greater awareness amongst clinicians may help make a positive diagnosis in the short window of time available. Little is known about its pathogenesis, and even less about optimal management strategies. We review the literature to demonstrate the clinical characteristics that might provide clues towards an ante mortem diagnosis, and highlight how imatinib may provide the key to treating PTTM.
Literature
1.
go back to reference Uruga H, Fujii T, Kurosaki A, Hanada S, Takaya H, Miyamoto A, et al. Pulmonary tumor thrombotic microangiopathy: a clinical analysis of 30 autopsy cases. Intern Med. 2013;52(12):1317–23.CrossRefPubMed Uruga H, Fujii T, Kurosaki A, Hanada S, Takaya H, Miyamoto A, et al. Pulmonary tumor thrombotic microangiopathy: a clinical analysis of 30 autopsy cases. Intern Med. 2013;52(12):1317–23.CrossRefPubMed
2.
go back to reference von Herbay A, Illes A, Waldherr R, Otto HF. Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer. 1990;66(3):587–92.CrossRef von Herbay A, Illes A, Waldherr R, Otto HF. Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer. 1990;66(3):587–92.CrossRef
3.
go back to reference Sato Y, Marutsuka K, Asada Y, Yamada M, Setoguchi T, Sumiyoshi A. Pulmonary tumor thrombotic microangiopathy. Pathol Int. 1995;45(6):436–40.CrossRefPubMed Sato Y, Marutsuka K, Asada Y, Yamada M, Setoguchi T, Sumiyoshi A. Pulmonary tumor thrombotic microangiopathy. Pathol Int. 1995;45(6):436–40.CrossRefPubMed
4.
go back to reference Shih H-M, Lin C-C, Shiao Y-W. Pulmonary tumor thrombotic microangiopathy. Am J Emerg Med. 2011;29(2):241.e3–4.CrossRef Shih H-M, Lin C-C, Shiao Y-W. Pulmonary tumor thrombotic microangiopathy. Am J Emerg Med. 2011;29(2):241.e3–4.CrossRef
5.
go back to reference Keenan NG, Nicholson AG, Oldershaw PJ. Fatal acute pulmonary hypertension caused by pulmonary tumour thrombotic microangiopathy. Int J Cardiol. 2008;124(1):e11–3.CrossRefPubMed Keenan NG, Nicholson AG, Oldershaw PJ. Fatal acute pulmonary hypertension caused by pulmonary tumour thrombotic microangiopathy. Int J Cardiol. 2008;124(1):e11–3.CrossRefPubMed
6.
go back to reference Kuwabara H, Yoshida S, Takasu T, Yuki M, Goto I, Hanafusa T, et al. Pulmonary tumor thrombotic microangiopathy caused by gastric cancer. Ann Thorac Med. 2012;7(3):168–9.CrossRefPubMedPubMedCentral Kuwabara H, Yoshida S, Takasu T, Yuki M, Goto I, Hanafusa T, et al. Pulmonary tumor thrombotic microangiopathy caused by gastric cancer. Ann Thorac Med. 2012;7(3):168–9.CrossRefPubMedPubMedCentral
7.
go back to reference Franquet T, Giménez A, Prats R, Rodríguez-Arias JM, Rodríguez C. Thrombotic microangiopathy of pulmonary tumors: a vascular cause of tree-in-bud pattern on CT. AJR Am J Roentgenol. 2002;179(4):897–9.CrossRefPubMed Franquet T, Giménez A, Prats R, Rodríguez-Arias JM, Rodríguez C. Thrombotic microangiopathy of pulmonary tumors: a vascular cause of tree-in-bud pattern on CT. AJR Am J Roentgenol. 2002;179(4):897–9.CrossRefPubMed
8.
go back to reference Guimarães MD, Almeida MFA, Brelinger A, Barbosa PN, Chojniak R, Gross JL. Diffuse bronchiolitis pattern on a computed tomography scan as a presentation of pulmonary tumor thrombotic microangiopathy: a case report. J Med Case Rep. 2011;5:575.CrossRefPubMedPubMedCentral Guimarães MD, Almeida MFA, Brelinger A, Barbosa PN, Chojniak R, Gross JL. Diffuse bronchiolitis pattern on a computed tomography scan as a presentation of pulmonary tumor thrombotic microangiopathy: a case report. J Med Case Rep. 2011;5:575.CrossRefPubMedPubMedCentral
9.
go back to reference Abe H, Hino R, Fukayama M. Platelet-derived growth factor-A and vascular endothelial growth factor-C contribute to the development of pulmonary tumor thrombotic microangiopathy in gastric cancer. Virchows Arch. 2013;462(5):523–31.CrossRefPubMed Abe H, Hino R, Fukayama M. Platelet-derived growth factor-A and vascular endothelial growth factor-C contribute to the development of pulmonary tumor thrombotic microangiopathy in gastric cancer. Virchows Arch. 2013;462(5):523–31.CrossRefPubMed
10.
go back to reference Okubo Y, Wakayama M, Kitahara K, Nemoto T, Yokose T, Abe F, et al. Pulmonary tumor thrombotic microangiopathy induced by gastric carcinoma: morphometric and immunohistochemical analysis of six autopsy cases. Diagn Pathol. 2011;6(1):27.CrossRefPubMedPubMedCentral Okubo Y, Wakayama M, Kitahara K, Nemoto T, Yokose T, Abe F, et al. Pulmonary tumor thrombotic microangiopathy induced by gastric carcinoma: morphometric and immunohistochemical analysis of six autopsy cases. Diagn Pathol. 2011;6(1):27.CrossRefPubMedPubMedCentral
11.
go back to reference Yokomine T, Hirakawa H, Ozawa E, Shibata K, Nakayama T. Pulmonary thrombotic microangiopathy caused by gastric carcinoma. J Clin Pathol. 2010;63(4):367–9.CrossRefPubMedPubMedCentral Yokomine T, Hirakawa H, Ozawa E, Shibata K, Nakayama T. Pulmonary thrombotic microangiopathy caused by gastric carcinoma. J Clin Pathol. 2010;63(4):367–9.CrossRefPubMedPubMedCentral
12.
go back to reference Hotta M, Ishida M, Kojima F, Iwai Y, Okabe H. Pulmonary tumor thrombotic microangiopathy caused by lung adenocarcinoma: Case report with review of the literature. Oncol Lett. 2011;2(3):435–7.PubMedPubMedCentral Hotta M, Ishida M, Kojima F, Iwai Y, Okabe H. Pulmonary tumor thrombotic microangiopathy caused by lung adenocarcinoma: Case report with review of the literature. Oncol Lett. 2011;2(3):435–7.PubMedPubMedCentral
13.
go back to reference Takahashi F, Kumasaka T, Nagaoka T, Wakiya M, Fujii H, Shimizu K, et al. Osteopontin expression in pulmonary tumor thrombotic microangiopathy caused by gastric carcinoma. Pathol Int. 2009;59(10):752–6.CrossRefPubMed Takahashi F, Kumasaka T, Nagaoka T, Wakiya M, Fujii H, Shimizu K, et al. Osteopontin expression in pulmonary tumor thrombotic microangiopathy caused by gastric carcinoma. Pathol Int. 2009;59(10):752–6.CrossRefPubMed
14.
go back to reference Patrignani A, Purcaro A, Calcagnoli F, Mandolesi A, Bearzi I, Ciampani N. Pulmonary tumor thrombotic microangiopathy: the challenge of the antemortem diagnosis. J Cardiovasc Med (Hagerstown). 2014;15(11):828–33.CrossRef Patrignani A, Purcaro A, Calcagnoli F, Mandolesi A, Bearzi I, Ciampani N. Pulmonary tumor thrombotic microangiopathy: the challenge of the antemortem diagnosis. J Cardiovasc Med (Hagerstown). 2014;15(11):828–33.CrossRef
15.
go back to reference Noguchi S, Imanaga T, Shimizu M, Nakano T, Miyazaki N. [Case of pulmonary tumor thrombotic microangiopathy diagnosed by transbronchial lung biopsy]. Nihon Kokyuki Gakkai Zasshi. 2008;46(6):493–6.PubMed Noguchi S, Imanaga T, Shimizu M, Nakano T, Miyazaki N. [Case of pulmonary tumor thrombotic microangiopathy diagnosed by transbronchial lung biopsy]. Nihon Kokyuki Gakkai Zasshi. 2008;46(6):493–6.PubMed
16.
go back to reference Ishiguro T, Takayanagi N, Ando M, Yanagisawa T, Shimizu Y, Sugita Y. [Pulmonary tumor thrombotic microangiopathy responding to chemotherapy]. Nihon Kokyuki Gakkai Zasshi. 2011;49(9):681–7.PubMed Ishiguro T, Takayanagi N, Ando M, Yanagisawa T, Shimizu Y, Sugita Y. [Pulmonary tumor thrombotic microangiopathy responding to chemotherapy]. Nihon Kokyuki Gakkai Zasshi. 2011;49(9):681–7.PubMed
17.
go back to reference Ueda A, Fuse N, Fujii S, Sasaki T, Sugiyama J, Kojima T, et al. Pulmonary tumor thrombotic microangiopathy associated with esophageal squamous cell carcinoma. Intern Med. 2011;50(22):2807–10.CrossRefPubMed Ueda A, Fuse N, Fujii S, Sasaki T, Sugiyama J, Kojima T, et al. Pulmonary tumor thrombotic microangiopathy associated with esophageal squamous cell carcinoma. Intern Med. 2011;50(22):2807–10.CrossRefPubMed
18.
go back to reference Ogawa A, Yamadori I, Matsubara O, Matsubara H. Pulmonary tumor thrombotic microangiopathy with circulatory failure treated with imatinib. Intern Med. 2013;52(17):1927–30.CrossRefPubMed Ogawa A, Yamadori I, Matsubara O, Matsubara H. Pulmonary tumor thrombotic microangiopathy with circulatory failure treated with imatinib. Intern Med. 2013;52(17):1927–30.CrossRefPubMed
19.
go back to reference Kitamura A, Nishimura N, Jinta T, Suda R, Yamano Y, Ishikawa G, et al. A case of pulmonary tumor thrombotic microangiopathy diagnosed by transbronchial lung biopsy and treated with chemotherapy and long-term oxygen and anticoagulation therapies. Case Rep Pulmonol. 2013;2013:259080.PubMedPubMedCentral Kitamura A, Nishimura N, Jinta T, Suda R, Yamano Y, Ishikawa G, et al. A case of pulmonary tumor thrombotic microangiopathy diagnosed by transbronchial lung biopsy and treated with chemotherapy and long-term oxygen and anticoagulation therapies. Case Rep Pulmonol. 2013;2013:259080.PubMedPubMedCentral
20.
go back to reference Miyano S, Izumi S, Takeda Y, Tokuhara M, Mochizuki M, Matsubara O, et al. Pulmonary tumor thrombotic microangiopathy. J Clin Oncol. 2007;25(5):597–9.CrossRefPubMed Miyano S, Izumi S, Takeda Y, Tokuhara M, Mochizuki M, Matsubara O, et al. Pulmonary tumor thrombotic microangiopathy. J Clin Oncol. 2007;25(5):597–9.CrossRefPubMed
21.
go back to reference Kayatani H, Matsuo K, Ueda Y, Matsushita M, Fujiwara K, Yonei T, et al. Pulmonary tumor thrombotic microangiopathy diagnosed antemortem and treated with combination chemotherapy. Intern Med. 2012;51(19):2767–70.CrossRefPubMed Kayatani H, Matsuo K, Ueda Y, Matsushita M, Fujiwara K, Yonei T, et al. Pulmonary tumor thrombotic microangiopathy diagnosed antemortem and treated with combination chemotherapy. Intern Med. 2012;51(19):2767–70.CrossRefPubMed
22.
go back to reference Uruga H, Morokawa N, Enomoto T, Takaya H, Miyamoto A, Kishi K. [A case of pulmonary tumor thrombotic microangiopathy associated with lung adenocarcinoma diagnosed by CT-guided lung biopsy]. Nihon Kokyuki Gakkai Zasshi. 2008;46(11):928–33.PubMed Uruga H, Morokawa N, Enomoto T, Takaya H, Miyamoto A, Kishi K. [A case of pulmonary tumor thrombotic microangiopathy associated with lung adenocarcinoma diagnosed by CT-guided lung biopsy]. Nihon Kokyuki Gakkai Zasshi. 2008;46(11):928–33.PubMed
23.
go back to reference Fukada I, Araki K, Minatsuki S, Fujino T, Hatano M, Numakura S, et al. Imatinib Alleviated Pulmonary Hypertension Caused by Pulmonary Tumor Thrombotic Microangiopathy in a Patient With Metastatic Breast Cancer. Clin Breast Cancer. 2015;15(2):e167–70.CrossRefPubMed Fukada I, Araki K, Minatsuki S, Fujino T, Hatano M, Numakura S, et al. Imatinib Alleviated Pulmonary Hypertension Caused by Pulmonary Tumor Thrombotic Microangiopathy in a Patient With Metastatic Breast Cancer. Clin Breast Cancer. 2015;15(2):e167–70.CrossRefPubMed
24.
go back to reference Higo K, Kubota K, Takeda A, Higashi M, Ohishi M. Successful antemortem diagnosis and treatment of pulmonary tumor thrombotic microangiopathy. Intern Med. 2014;53(22):2595–9.CrossRefPubMed Higo K, Kubota K, Takeda A, Higashi M, Ohishi M. Successful antemortem diagnosis and treatment of pulmonary tumor thrombotic microangiopathy. Intern Med. 2014;53(22):2595–9.CrossRefPubMed
25.
go back to reference Ghofrani HA, Seeger W, Grimminger F. Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med. 2005;353(13):1412–3.CrossRefPubMed Ghofrani HA, Seeger W, Grimminger F. Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med. 2005;353(13):1412–3.CrossRefPubMed
27.
go back to reference Fallowfield LJ, Hall A, Maguire GP, Baum M. Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ. 1990;301(6752):575–80.CrossRefPubMedPubMedCentral Fallowfield LJ, Hall A, Maguire GP, Baum M. Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ. 1990;301(6752):575–80.CrossRefPubMedPubMedCentral
29.
go back to reference Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, Grambow S, Parker J. Preparing for the end of life: preferences of patients, families, physicians, and other care providers. J Pain Symptom Manage. 2001;22(3):727–37.CrossRef Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, Grambow S, Parker J. Preparing for the end of life: preferences of patients, families, physicians, and other care providers. J Pain Symptom Manage. 2001;22(3):727–37.CrossRef
Metadata
Title
The diagnostic challenge of pulmonary tumour thrombotic microangiopathy as a presentation for metastatic gastric cancer: a case report and review of the literature
Authors
Andrew LK. Ho
Patryk Szulakowsi
Waria HS. Mohamid
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2015
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-015-1467-7

Other articles of this Issue 1/2015

BMC Cancer 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine